Hosaka K, Murakami T, Kodaki T, Nikawa J, Yamashita S
Department of Biochemistry, Gunma University School of Medicine, Maebashi, Japan.
J Bacteriol. 1990 Apr;172(4):2005-12. doi: 10.1128/jb.172.4.2005-2012.1990.
The regulation of choline kinase (EC 2.7.1.32), the initial enzyme in the CDP-choline pathway, was examined in Saccharomyces cerevisiae. The addition of myo-inositol to a culture of wild-type cells resulted in a significant decrease in choline kinase activity. Additional supplementation of choline caused a further reduction in the activity. The coding frame of the choline kinase gene, CK1, was joined to the carboxyl terminus of lacZ and expressed in Escherichia coli as a fusion protein, which was then used to prepare an anti-choline kinase antibody. Upon Western (immuno-) and Northern (RNA) blot analyses using the antibody and a CK1 probe, respectively, the decrease in the enzyme activity was found to be correlated with decreases in the enzyme amount and mRNA abundance. The molecular mass of the enzyme was estimated to be 66 kilodaltons, in agreement with the value predicted previously from the nucleotide sequence of the gene. The coding region of CK1 was replaced with that of lacZ, and CK1 expression was measured by assaying beta-galactosidase. The expression of beta-galactosidase from this fusion was repressed by myo-inositol and choline and derepressed in a time-dependent manner upon their removal. The present findings indicate that yeast choline kinase is regulated by myo-inositol and choline at the level of mRNA abundance.
在酿酒酵母中研究了CDP-胆碱途径中的起始酶胆碱激酶(EC 2.7.1.32)的调控。向野生型细胞培养物中添加肌醇会导致胆碱激酶活性显著降低。额外补充胆碱会使活性进一步降低。胆碱激酶基因CK1的编码框与lacZ的羧基末端连接,并作为融合蛋白在大肠杆菌中表达,然后用于制备抗胆碱激酶抗体。分别使用该抗体和CK1探针进行蛋白质免疫印迹(Western blot)和RNA印迹(Northern blot)分析时,发现酶活性的降低与酶量和mRNA丰度的降低相关。该酶的分子量估计为66千道尔顿,与先前根据基因核苷酸序列预测的值一致。用lacZ的编码区替换CK1的编码区,并通过测定β-半乳糖苷酶来检测CK1的表达。这种融合体中β-半乳糖苷酶的表达受到肌醇和胆碱的抑制,去除它们后会随时间解除抑制。目前的研究结果表明,酵母胆碱激酶在mRNA丰度水平上受到肌醇和胆碱的调控。